New prospects for PCSK9 inhibition

, Ulf Landmesser (Lead / Corresponding author), M. John Chapman, Jane K. Stock, Pierre Amarenco, Jill J. F. Belch, Jan Borén, Michel Farnier, Brian A. Ference, Stephan Gielen, Ian Graham, Diederick E. Grobbee, G. Kees Hovingh, Thomas F. Luscher, Massimo F. Piepoli, Kausik K. Ray, Erik S. Stroes, Olov Wiklund, Stephan Windecker, Jose Luis ZamoranoFausto Pinto, Lale Tokgozoglu, Jeroen J. Bax, Alberico L. Catapano

Research output: Contribution to journalComment/debate

Abstract

This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia’, by U Landmesser et al., doi: 10.1093/eurheartj/ehx549.
Original languageEnglish
Pages (from-to)2600-2601
Number of pages2
JournalEuropean Heart Journal
Volume39
Issue number27
Early online date22 Mar 2018
DOIs
Publication statusPublished - 14 Jul 2018

Fingerprint

Hyperlipoproteinemia Type II
Advisory Committees
Cardiovascular Diseases
Proprotein Convertase 9

Cite this

, Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., ... Catapano, A. L. (2018). New prospects for PCSK9 inhibition. European Heart Journal, 39(27), 2600-2601. https://doi.org/10.1093/eurheartj/ehy147
Landmesser, Ulf ; Chapman, M. John ; Stock, Jane K. ; Amarenco, Pierre ; Belch, Jill J. F. ; Borén, Jan ; Farnier, Michel ; Ference, Brian A. ; Gielen, Stephan ; Graham, Ian ; Grobbee, Diederick E. ; Hovingh, G. Kees ; Luscher, Thomas F. ; Piepoli, Massimo F. ; Ray, Kausik K. ; Stroes, Erik S. ; Wiklund, Olov ; Windecker, Stephan ; Zamorano, Jose Luis ; Pinto, Fausto ; Tokgozoglu, Lale ; Bax, Jeroen J. ; Catapano, Alberico L. / New prospects for PCSK9 inhibition. In: European Heart Journal. 2018 ; Vol. 39, No. 27. pp. 2600-2601.
@article{e89d5cae708248dd826dd317c48bec50,
title = "New prospects for PCSK9 inhibition",
abstract = "This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia’, by U Landmesser et al., doi: 10.1093/eurheartj/ehx549.",
author = "Ulf Landmesser and Chapman, {M. John} and Stock, {Jane K.} and Pierre Amarenco and Belch, {Jill J. F.} and Jan Bor{\'e}n and Michel Farnier and Ference, {Brian A.} and Stephan Gielen and Ian Graham and Grobbee, {Diederick E.} and Hovingh, {G. Kees} and Luscher, {Thomas F.} and Piepoli, {Massimo F.} and Ray, {Kausik K.} and Stroes, {Erik S.} and Olov Wiklund and Stephan Windecker and Zamorano, {Jose Luis} and Fausto Pinto and Lale Tokgozoglu and Bax, {Jeroen J.} and Catapano, {Alberico L.}",
year = "2018",
month = "7",
day = "14",
doi = "10.1093/eurheartj/ehy147",
language = "English",
volume = "39",
pages = "2600--2601",
journal = "European Heart Journal",
issn = "0195-668X",
publisher = "Oxford University Press",
number = "27",

}

Landmesser, U, Chapman, MJ, Stock, JK, Amarenco, P, Belch, JJF, Borén, J, Farnier, M, Ference, BA, Gielen, S, Graham, I, Grobbee, DE, Hovingh, GK, Luscher, TF, Piepoli, MF, Ray, KK, Stroes, ES, Wiklund, O, Windecker, S, Zamorano, JL, Pinto, F, Tokgozoglu, L & Bax, JJ & Catapano, AL 2018, 'New prospects for PCSK9 inhibition', European Heart Journal, vol. 39, no. 27, pp. 2600-2601. https://doi.org/10.1093/eurheartj/ehy147

New prospects for PCSK9 inhibition. /; Landmesser, Ulf (Lead / Corresponding author); Chapman, M. John; Stock, Jane K.; Amarenco, Pierre; Belch, Jill J. F.; Borén, Jan; Farnier, Michel; Ference, Brian A.; Gielen, Stephan; Graham, Ian; Grobbee, Diederick E.; Hovingh, G. Kees; Luscher, Thomas F.; Piepoli, Massimo F.; Ray, Kausik K.; Stroes, Erik S.; Wiklund, Olov; Windecker, Stephan; Zamorano, Jose Luis; Pinto, Fausto; Tokgozoglu, Lale; Bax, Jeroen J.; Catapano, Alberico L.

In: European Heart Journal, Vol. 39, No. 27, 14.07.2018, p. 2600-2601.

Research output: Contribution to journalComment/debate

TY - JOUR

T1 - New prospects for PCSK9 inhibition

AU - Landmesser, Ulf

AU - Chapman, M. John

AU - Stock, Jane K.

AU - Amarenco, Pierre

AU - Belch, Jill J. F.

AU - Borén, Jan

AU - Farnier, Michel

AU - Ference, Brian A.

AU - Gielen, Stephan

AU - Graham, Ian

AU - Grobbee, Diederick E.

AU - Hovingh, G. Kees

AU - Luscher, Thomas F.

AU - Piepoli, Massimo F.

AU - Ray, Kausik K.

AU - Stroes, Erik S.

AU - Wiklund, Olov

AU - Windecker, Stephan

AU - Zamorano, Jose Luis

AU - Pinto, Fausto

AU - Tokgozoglu, Lale

AU - Bax, Jeroen J.

AU - Catapano, Alberico L.

PY - 2018/7/14

Y1 - 2018/7/14

N2 - This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia’, by U Landmesser et al., doi: 10.1093/eurheartj/ehx549.

AB - This commentary refers to ‘2017 update of ESC/EAS task force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia’, by U Landmesser et al., doi: 10.1093/eurheartj/ehx549.

U2 - 10.1093/eurheartj/ehy147

DO - 10.1093/eurheartj/ehy147

M3 - Comment/debate

C2 - 29579192

VL - 39

SP - 2600

EP - 2601

JO - European Heart Journal

JF - European Heart Journal

SN - 0195-668X

IS - 27

ER -

Landmesser U, Chapman MJ, Stock JK, Amarenco P, Belch JJF et al. New prospects for PCSK9 inhibition. European Heart Journal. 2018 Jul 14;39(27):2600-2601. https://doi.org/10.1093/eurheartj/ehy147